ImmunityBio, Inc. IBRX Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s other non-current liabilities?
- ImmunityBio, Inc. (IBRX) reported other non-current liabilities of $472K in Q1 2026.
- How has ImmunityBio, Inc.'s other non-current liabilities changed year-over-year?
- ImmunityBio, Inc.'s other non-current liabilities increased by 27.6% year-over-year, from $370K to $472K.
- What is the long-term trend for ImmunityBio, Inc.'s other non-current liabilities?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s other non-current liabilities has grown at a -16.3% compound annual growth rate (CAGR), from $1.04M to $424K.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.